PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy

PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy

Diabetic cardiomyopathy (DCM) is a specific type of myocardial disease that often develops in patients suffering from diabetes, which has become the foremost cause of death among them. It is an insidious multifactorial disease caused by complex and partially unknown mechanisms that include metabolic...

Saved in:

書目詳細資料
Main Authors:	Rostami, Adel, Palomer, Xavier, Pizarro-Delgado, Javier, Barroso, Emma, Valenzuela-Alcaraz, Brenda, Crispi, Fátima, Nistal, J. Francisco, Hurlé, María A., García, Raquel, Wahli, Walter, Vázquez-Carrera, Manuel
其他作者:	Lee Kong Chian School of Medicine (LKCMedicine)
格式:	Article
語言:	English
出版:	2025
主題:	Medicine, Health and Life Sciences Diabetic cardiomyopathy Fibrosis
在線閱讀:	https://hdl.handle.net/10356/183670
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells
由: Zhang, Meijian, et al.
出版: (2024)

Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression
由: Sng, Ming Keat, et al.
出版: (2018)

Subclinical Cardiomyopathy in Miyoshi Myopathy Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging A Case for Routine Cardiac Screening?
由: Tan, Sarah Ming Li, et al.
出版: (2022)

Diverse clinical spectrum of stress-induced cardiomyopathy
由: Lee, Y.-P., et al.
出版: (2015)

Hereditary transthyretin amyloid cardiomyopathy
由: Zheng, Y, et al.
出版: (2023)

GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK
由: Aguilar-Recarte, David, et al.
出版: (2021)

Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes
由: Zarei, Mohammad, et al.
出版: (2020)

Hypertrophic Cardiomyopathy: From Genes to Bedside
由: Objoon Trachoo, et al.
出版: (2022)

The use of vasopressors in Takotsubo cardiomyopathy: Impact on neurological practice
由: Rathakrishnan, R., et al.
出版: (2016)

Takotsubo cardiomyopathy associated with status epilepticus
由: Seow, S.-C., et al.
出版: (2014)

qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients
由: Xu, Shuoyu, et al.
出版: (2016)

Titin truncating mutations: A rare cause of dilated cardiomyopathy in the young
由: Fatkin D., et al.
出版: (2019)

MOLECULAR DISSECTION OF CARDIOMYOPATHY
由: PUA CHEE JIAN
出版: (2021)

Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation
由: Lin, Yubi, et al.
出版: (2022)

A surgically correctable cause of dilated cardiomyopathy in infancy
由: Quek, S.C., et al.
出版: (2013)

PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
由: Salvadó, Laia, et al.
出版: (2014)

Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy
由: Heinig M., et al.
出版: (2019)

Candida albicans in cystic fibrosis: “Opening statements presented, let the trial begin”
由: Chotirmall, Sanjay Haresh
出版: (2017)

An analysis of an Ising-like agent based model of lung inflammation and fibrosis in response to particulate matter using a Netlogo v6.0 platform
由: Caballero, Rafael Martin R.
出版: (2017)

PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells
由: Palomer, Xavier, et al.
出版: (2014)

Chitinase activation in patients with fungus-associated cystic fibrosis lung disease
由: Hector, Andreas, et al.
出版: (2017)

Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
由: Segar, Matthew W., et al.
出版: (2022)

Electrophysiological and structural remodeling of the atria in a mouse model of troponin-i mutation linked hypertrophic cardiomyopathy: Implications for atrial fibrillation
由: Lim, Wei-Wen, et al.
出版: (2022)

Cytoskeleton Regulators in the Control of Corneal Fibrosis
由: ZHU HONGYUAN
出版: (2013)

Understanding arrhythmogenic right ventricular cardiomyopathy: Use of patient-specific induced pluripotent stem cell models
由: Yap, J., et al.
出版: (2016)

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy
由: Horvat C., et al.
出版: (2018)

Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia
由: Lin, Weiqin, et al.
出版: (2022)

Subtype Specificity of Adenosine A2 Receptor on the Inhibition of Angiotensin II-induced Cardiac Fibrosis
由: Kwanchai Bunrukchai, et al.
出版: (2021)

Noncompaction cardiomyopathy presenting with congestive heart failure during intercurrent dengue viral illness: Importance of phenotypic recognition [7]
由: Neo, H.-Y., et al.
出版: (2011)

Noncompaction cardiomyopathy presenting with congestive heart failure during intercurrent dengue viral illness: Importance of phenotypic recognition [7]
由: Neo, H.-Y., et al.
出版: (2016)

The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy
由: Gulati A., et al.
出版: (2019)

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
由: Leow, W.-Q., et al.
出版: (2021)

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: Recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel
由: Kelly, M.A, et al.
出版: (2020)

Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning
由: Crisafulli, A., et al.
出版: (2021)

Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients
由: Nogue Infante, Anna, et al.
出版: (2023)

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy
由: Walsh, R., et al.
出版: (2021)

Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
由: Tan, Nguan Soon, et al.
出版: (2017)

EXPLORING TARGETED AND NON-TARGETED APPROACHES IN THE DEVELOPMENT OF ANTI-FIBROTIC THERAPY FOR LIVER FIBROSIS
由: SOH KAR LING CARRIE
出版: (2017)

Cerium Oxide Nanoparticles Alleviate Hepatic Fibrosis Phenotypes In Vitro
由: Boey, Adrian, et al.
出版: (2022)

Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy
由: Gulati A., et al.
出版: (2018)